Table 3.

Patients who underwent plasma sodium relowering

Patient No.Variables before DDAVP and ReloweringFirst Relowering EpisodeSubsequent Relowering Episodes
PNai (mmol/L)aPNabef (mmol/L)Time to Relowering (h:min)bΔRelowering (mmol/L)cEpisode Duration (h:min)dPNa Relowering Rate (mmol/L per hour)Subsequent Episode(s)PNanadirePNa Relowering Rate at PNanadir (mmol/L per hour)
Level of PNanadir (mmol/L)Time to Nadir (h:min)
3f11011902:30510:000.50Yes11410:000.50
41071194:0049:000.44Yes11326:450.22
510912402:3065:001.20Yes11610:150.78
71181285:30317:000.18Yes11947:300.19
131091315:0067:000.86Yes11923:000.52
141191424:0024:450.42Yes12722:300.67
15f10712205:15413:300.30No11805:150.30
16f10711912:00334:000.09No11612:000.09
17f10712702:30626:450.22No12102:300.22
18f10711804:00815:000.53Yes11015:000.53
19f10912012:45517:150.29Yes11512:450.29
  • PNanadir, lowest PNa recorded after the first DDAVP administration.

  • a PNa at hospital admission.

  • b Time elapsed between the first DDAVP injection and the first PNa evidencing a decrease in PNa levels after the first DDAVP injection.

  • c Difference between PNabef and the minimal PNa recorded during the first episode of PNa relowering. Results are expressed as absolute values.

  • d Time elapsed between consecutive decreases in PNa levels.

  • e Lowest PNa recorded after the first DDAVP administration.

  • f The PNanadir was recorded at the first episode of relowering.